Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
J Cardiol
    June 2025
  1. AIZAWA N, Tanno K, Furuya T, Ishinaga T, et al
    Very high-power short-duration ablation for superior vena cava isolation in patients with recurrent atrial fibrillation.
    J Cardiol. 2025 Jun 28:S0914-5087(25)00168-6. doi: 10.1016/j.jjcc.2025.
    >> Share

    May 2025
  2. YAMAGISHI Y, Watabe T, Nakahara D, Taniguchi K, et al
    Characteristics of anxiety about returning to work after implantable cardioverter defibrillator implantation in Japan.
    J Cardiol. 2025 May 30:S0914-5087(25)00143-1. doi: 10.1016/j.jjcc.2025.
    >> Share

  3. AIJAZ A, Magsi IA, Zeeshan I
    Critique on "mitral regurgitation in atrial fibrillation: is a simple repair enough to tackle a complex problem?".
    J Cardiol. 2025 May 27:S0914-5087(25)00135-2. doi: 10.1016/j.jjcc.2025.
    >> Share

    April 2025
  4. NAKANO T, Oka T, Okayama K, Tanaka N, et al
    Association between oral anticoagulants continuation on thromboembolism and bleeding events in patients with CHADS(2) score 0-2 points after catheter ablation for persistent atrial fibrillation.
    J Cardiol. 2025 Apr 24:S0914-5087(25)00103-0. doi: 10.1016/j.jjcc.2025.
    >> Share

  5. NISHINARITA R, Oikawa J, Arao K, Sugisaki K, et al
    Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation.
    J Cardiol. 2025 Apr 2:S0914-5087(25)00097-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  6. SHINOHARA M, Saji M, Koike H, Ohara H, et al
    Current evidence and indications for left atrial appendage closure.
    J Cardiol. 2025;85:268-274.
    >> Share

    March 2025
  7. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  8. AWAD AK, Elbahloul MA, Gamal A, Attia AN, et al
    Efficacy of surgical ablation and left atrial appendage occlusion in patients with AF undergoing coronary artery bypass grafting: A network meta-analysis.
    J Cardiol. 2025;85:177-185.
    >> Share

  9. KAWAJI T, Hayashi T, Nishimura T, Nagashima K, et al
    3D mapping quest: How far can we see with recent advances in 3D mapping?
    J Cardiol. 2025;85:204-212.
    >> Share

    February 2025
  10. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    Author's reply to "how to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation".
    J Cardiol. 2025 Feb 14:S0914-5087(25)00063-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  11. TALPUR H, Mustafa G
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2025 Feb 13:S0914-5087(25)00059-0. doi: 10.1016/j.jjcc.2025.
    >> Share

  12. ALBAKAA NK, Sato K, Kawamatsu N, Yamamoto M, et al
    Imaging characteristics of patients with cardiac sarcoidosis who presented with ventricular arrhythmias.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00035-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  13. KATAOKA N, Imamura T
    How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2025 Feb 6:S0914-5087(25)00020-6. doi: 10.1016/j.jjcc.2025.
    >> Share

  14. DIMITRIADIS K, Pyrpyris N, Iliakis P, Kanatas P, et al
    Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
    J Cardiol. 2025;85:79-87.
    >> Share

  15. WAKAMATSU Y, Nagashima K, Watanabe R, Hirata S, et al
    Beyond the lens: Unveiling the invisible atrioventricular node in the era of high-density mapping.
    J Cardiol. 2025;85:56-62.
    >> Share

    January 2025
  16. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  17. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    >> Share

  18. BAZOUKIS G, Hui JMH, Saplaouras A, Efthymiou P, et al
    The impact of new-onset atrial fibrillation in the setting of acute coronary syndrome.
    J Cardiol. 2025 Jan 7:S0914-5087(24)00233-8. doi: 10.1016/j.jjcc.2024.
    >> Share

  19. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    >> Share

    December 2024
  20. KHAN S, Javed R, Amin S
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2024 Dec 12:S0914-5087(24)00226-0. doi: 10.1016/j.jjcc.2024.
    >> Share

  21. KAMADA H, Iriki Y, Yoshimoto I, Ninomiya Y, et al
    Incidence and predictors of persistent iatrogenic atrial septal defect following catheter ablation.
    J Cardiol. 2024;84:372-378.
    >> Share

    October 2024
  22. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    >> Share

    September 2024
  23. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    The role of left atrium posterior wall isolation in patients undergoing catheter ablation for atrial fibrillation.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00180-1. doi: 10.1016/j.jjcc.2024.
    >> Share

  24. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    >> Share

  25. MATSUOKA Y, Sotomi Y, Hikoso S, Sunaga A, et al
    Extensive ablation for elderly patients with persistent atrial fibrillation: insights from the EARNEST-PVI prospective randomized trial.
    J Cardiol. 2024 Sep 7:S0914-5087(24)00173-4. doi: 10.1016/j.jjcc.2024.
    >> Share

    August 2024
  26. YOSHII T, Amano M, Moriuchi K, Nakagawa S, et al
    Usefulness of exercise stress echocardiography for predicting cardiovascular events and atrial fibrillation in hypertrophic cardiomyopathy.
    J Cardiol. 2024 Aug 28:S0914-5087(24)00170-9. doi: 10.1016/j.jjcc.2024.
    >> Share

  27. ROMERO CE, Pereira NM, Morales KP, Kerges Bueno BV, et al
    Echocardiographic factors associated with thromboembolic events in patients with cardiac amyloidosis without atrial fibrillation.
    J Cardiol. 2024 Aug 9:S0914-5087(24)00147-3. doi: 10.1016/j.jjcc.2024.
    >> Share

    June 2024
  28. OKISHIGE K, Tachibana S, Shigeta T, Yamauchi Y, et al
    Novel method to avoid serious injurious effects on the atrioventricular nodal (AVN) conduction during catheter ablation of the AVN slow pathway utilizing cryofreezing energy.
    J Cardiol. 2024;83:371-376.
    >> Share

    May 2024
  29. YAMAGUCHI T
    Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective.
    J Cardiol. 2024 May 27:S0914-5087(24)00096-0. doi: 10.1016/j.jjcc.2024.
    >> Share

  30. KURODA S, Kawamura I, Sahashi Y, Kuno T, et al
    The significance of non-sustained ventricular tachycardia on life-threatening ventricular arrhythmia events in patients with non-ischemic cardiomyopathy in the contemporary era: A systematic review and meta-analysis.
    J Cardiol. 2024 May 14:S0914-5087(24)00086-8. doi: 10.1016/j.jjcc.2024.
    >> Share

  31. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    >> Share

    March 2024
  32. BAZOUKIS G, Saplaouras A, Efthymiou P, Yiannikourides A, et al
    Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.
    J Cardiol. 2024 Mar 31:S0914-5087(24)00053-4. doi: 10.1016/j.jjcc.2024.
    >> Share

  33. IMBURGIO S, Johal A, Akhlaq H, Klei L, et al
    Fatal ventricular arrhythmias in myocarditis: A review of current indications for defibrillator devices.
    J Cardiol. 2024 Mar 27:S0914-5087(24)00054-6. doi: 10.1016/j.jjcc.2024.
    >> Share

    February 2024
  34. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    >> Share

    December 2023
  35. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    >> Share

    November 2023
  36. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
    Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
    J Cardiol. 2023;82:363-370.
    >> Share

  37. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    >> Share

    October 2023
  38. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  39. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    >> Share

    September 2023
  40. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016